Patients' perspectives and motivators to participate in clinical trials with novel therapies for rheumatoid arthritis.

PubWeight™: 0.87‹?›

🔗 View Article (PMC 3018984)

Published in J Med Life on January 29, 2010

Authors

G Udrea1, B Dumitrescu, M Purcarea, I Balan, E Rezus, D Deculescu

Author Affiliations

1: "Carol Davila" University of Medicine, Bucharest, Romania. gabiudrea@yahoo.com

Articles cited by this

Perceptions of cancer patients and their physicians involved in phase I trials. J Clin Oncol (1995) 5.86

False hopes and best data: consent to research and the therapeutic misconception. Hastings Cent Rep (1987) 5.64

Informed consent for clinical trials: in search of the "best" method. Soc Sci Med (1998) 2.90

Empirical assessment of whether moderate payments are undue or unjust inducements for participation in clinical trials. Arch Intern Med (2004) 2.49

Participation in a clinical trial: the patients' point of view. Control Clin Trials (1985) 2.41

Attitudes towards clinical research amongst participants and nonparticipants. J Intern Med (2002) 1.74

Attitudes toward research participation and investigator conflicts of interest among advanced cancer patients participating in early phase clinical trials. J Clin Oncol (2007) 1.74

Identifying motivations and barriers to patient participation in clinical trials. J Cancer Educ (2006) 1.61

Patients' attitudes to participation in clinical trials. Br J Clin Pharmacol (1993) 1.52

African Americans and participation in clinical trials: differences in beliefs and attitudes by gender. Contemp Clin Trials (2006) 1.51

Statewide Tuskegee Alliance for clinical trials. A community coalition to enhance minority participation in medical research. Cancer (2001) 1.29

Altruism as a reason for participation in clinical trials was independently associated with adherence. J Clin Epidemiol (2005) 1.21

Payment to healthcare professionals for patient recruitment to trials: systematic review and qualitative study. Health Technol Assess (2008) 1.19

Clinical trial participant satisfaction: survey of SHEP enrollees. SHEP Cooperative Research Group. Systolic Hypertension in the Elderly Program. J Am Geriatr Soc (1997) 1.19

Accrual to clinical trials. J Natl Cancer Inst (1988) 1.09

Patient accrual to clinical trials. Cancer Treat Rep (1987) 0.86

Some thoughts on the future of clinical trials in cancer. Cancer Treat Rep (1986) 0.79

Formative research in clinical trial development: attitudes of patients with arthritis in enhancing prevention trials. Ann Rheum Dis (2006) 0.78

Recruitment from clinical studies. Circulation (1982) 0.78

Articles by these authors

The crystal structure of an Eph receptor SAM domain reveals a mechanism for modular dimerization. Nat Struct Biol (1999) 1.85

AP1-mediated multidrug resistance in Saccharomyces cerevisiae requires FLR1 encoding a transporter of the major facilitator superfamily. J Biol Chem (1997) 1.72

A randomized controlled trial to test an HIV-prevention intervention for Latino gay and bisexual men: lessons learned. AIDS Care (2005) 1.28

Is 'bareback' a useful construct in primary HIV-prevention? Definitions, identity and research. Cult Health Sex (2009) 1.25

Progressive vertebral deformities despite unchanged bone mineral density in patients with sarcoidosis: a 4-year follow-up study. Osteoporos Int (2008) 0.85

Tyrosine hydroxylase- and/or aromatic L-amino acid decarboxylase-expressing neurons in the rat arcuate nucleus: ontogenesis and functional significance. Psychoneuroendocrinology (2002) 0.84

Use of Hemospray in the treatment of patients with acute UGIB - short review. J Med Life (2013) 0.82

Spontaneous esophageal mucosal dissection in a patient with upper digestive bleeding and esophageal varices. J Med Life (2011) 0.81

Antibacterial antibodies for some enterobacteria in sera of patients with reactive arthritis and other rheumatoid diseases. Roum Arch Microbiol Immunol (2009) 0.76

Role of colon capsule Pillcam 2 in obscure gastrointestinal bleeding - case report. J Med Life (2013) 0.75

[Non-dopaminergic neurons expressing dopamine synthesis enzymes: differentiation and functional importance]. Ross Fiziol Zh Im I M Sechenova (2000) 0.75